Data / Form D filings / Oncoscope Inc
Oncoscope Inc: Form D filings
Oncoscope Inc, a biotechnology company in Durham, NC, filed 5 Form D notices with the SEC between 2010 and 2012. The latest, on October 12, 2012, reports $449,964 sold of a $1 million offering to 23 investors.
Find out what Oncoscope Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 318 BLACKWELL STREET, SUITE 240, Durham, NC, 27701
- Phone
- (919) 251-8030
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1420865
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 12, 2012 | New notice | $1,000,000 | $449,964 | $550,036 | 23 | Oct 2, 2012 | sec.gov |
| Aug 25, 2011 | Amendment | $2,000,000 | $2,000,000 | $0 | 40 | Apr 11, 2011 | sec.gov |
| Jul 21, 2011 | Amendment | $2,000,000 | $890,737 | $1,109,263 | 34 | Apr 11, 2011 | sec.gov |
| Apr 21, 2011 | New notice | $1,000,000 | $624,902 | $375,098 | 25 | Apr 11, 2011 | sec.gov |
| May 18, 2010 | New notice | $1,519,154 | $1,198,184 | $320,970 | 20 | Apr 26, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Lister A Delgado | Director | |
| Adam A Wax | Director | |
| Matthew A Megaro | Director | |
| James A Dougherty | Director | |
| Paul A Priu | Director | |
| Perry A Genova | Executive Officer, Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Oct 8, 2012 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Oncoscope Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.